Results 161 to 170 of about 33,818 (248)

The Significance of Angiopoietin Valency in Vascular Health and Disease. [PDF]

Cells
Zhao YT, Ehnes DD, Mathieu J, Ruohola-Baker H.   +3 more
europepmc   +1 more source

Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical Experience. [PDF]

Biologics
Triana P, Marín E, Mendieta C, Fernández L, Rodriguez-Laguna L, Lopez-Gutierrez JC.   +5 more
europepmc   +1 more source

A human endothelial and adipose stem cell-based co-culture model for venous malformations. [PDF]

Angiogenesis
Ansarizadeh M, Lazovic B, Sarmadian Z, Singh A, Hicks R, Eklund L.   +5 more
europepmc   +1 more source

Dermal mesenchymal stem cells promote angiogenesis in HMEC-1 via activation of the angiopoietin 1/Tie2 pathway in psoriasis. [PDF]

Front Cell Dev Biol
Li J, Hou H, Xing J, Li J, Zhang K.
europepmc   +1 more source

Constitutive, Mosaic Expression of TIE2 p.L914F During Mouse Development Causes Venous Malformation. [PDF]

FASEB J
Bischoff LJ, Sherpa C, Schrenk S, Boscolo E.   +3 more
europepmc   +1 more source

Integrative In Silico and FFPE Tissue Analyses Elucidate Upregulated Genes in Colorectal Cancer Enriched for Tie2-Expressing Macrophages/Monocytes. [PDF]

Int J Mol Sci
Ali EAM, Altaie AM, Alhamidi RS, Ali N, Boghossian A, Almazrouei M, Mohan VB, Bendardaf R, Mohamed R, Talaat IM, Hamoudi R.   +10 more
europepmc   +1 more source

Characterizing vascular expression of Tie2/Tek during breast cancer progression

, 2009
Clinical efficacy of targeted anti-angiogenic therapy is dependent on target molecule expression by tumor blood vessels. Utilizing dual-immunostaining we have demonstrated marked heterogeneity in breast tumor blood vessel expression of the endothelial ...
Smith, Mackenzie Jonathan
core  

Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

Developmental Biology, 2001
Y. Kisanuki, Robert E. Hammer, J. Miyazaki, Clay K. Williams, James A. Richardson, M. Yanagisawa   +5 more
semanticscholar   +1 more source

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK. [PDF]

EClinicalMedicine
Morgan RD, Porter C, Zhou C, Kristeleit R, Desai S, Vazquez I, George A, Eminowicz G, Walther A, Franklin A, Sadozye AH, Hughes A, Hanna L, Roux R, Lord R, Bowen R, Wood J, Sentamans C, White A, Casbard AC, Humphrys A, Swettenham JB, Nixon LS, Adams R, Ray R, Brogden E, Powell WE, Canham J, Cox TM, Narasimham M, Lowe H, Ensell L, Zubair M, Morris K, Glenister-Doyle M, Gassio AF, Morgan D, Broughton D, Carucci M, Monaghan PJ, Tugwood J, Edmondson RJ, Dive C, Jayson GC, Clamp AR.   +44 more
europepmc   +1 more source

Urinary angiopoietin-2 as a biomarker of kidney outcomes in critical illness: same label, different signals. [PDF]

Crit Care
Zhang R.
europepmc   +1 more source